ARTICLE | Clinical News
MethylGene, MGI preclinical data
May 23, 2005 7:00 AM UTC
MG98 sensitized and overcame the resistance of human renal cancer cells to the effects of interferon (IFN) alpha. The DNA methyltransferase 1 inhibitor enhanced the effect of IFN alpha by demethylati...